Pfizer to Spend $120 Million to Boost U.S. COVID Pill Manufacturing



Pfizer Inc (PFE.N) said on Monday it would spend $120 million to expand manufacturing of its COVID-19 antiviral treatment at its Michigan plant, as demand ramps up. That sounds like a great investment!


Read more about it


Photo Credit: Alexander Mils

2 views0 comments